Tokushima-ken, Japan

Satoru Nakai


Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 145(Granted Patents)


Location History:

  • Takushima, JP (1994)
  • Itano, JP (1994 - 1995)
  • Itano-gun, JP (1998)
  • Tokushima, JP (1987 - 1999)
  • Tokushima-ken, JP (1996 - 2000)

Company Filing History:


Years Active: 1987-2000

Loading Chart...
27 patents (USPTO):Explore Patents

Title: **Satoru Nakai: Innovator in the Field of Pharmaceuticals**

Introduction: Satoru Nakai, based in Tokushima-ken, Japan, is an accomplished inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 27 patents, he has focused on innovations that aim to advance medical treatments and therapeutic compositions.

Latest Patents: Among his latest patents, Nakai has developed groundbreaking work on IL-1.beta. and its derivatives. This includes a homogeneous interleukin 1.beta. (IL-1.beta.), which features a modified amino acid sequence, as well as a gene coding for said derivative. His medical compositions utilize this derivative as a pharmaceutically effective component, ultimately focusing on its medicinal use. Additionally, he has created an apoptosis regulating composition that comprises carbostyril derivatives as an active ingredient, which is instrumental in regulating cell death processes.

Career Highlights: Nakai's career is marked by an impactful affiliation with Otsuka Pharmaceutical Company, Limited, where he has actively contributed to pharmaceutical development. His innovative mindset has allowed him to promote significant advancements in drug formulations and therapeutic applications.

Collaborations: Throughout his career, Satoru Nakai has collaborated with notable colleagues, including Yoshikatsu Hirai and Kazuyoshi Kawai. Together, they have combined their expertise to push the boundaries of pharmaceutical research and innovation.

Conclusion: Satoru Nakai's work exemplifies the spirit of innovation in the pharmaceutical industry. With his extensive patent portfolio and commitment to research, he continues to influence medical science and contribute to the development of therapeutic solutions that improve patient outcomes. His dedication to advancing the field makes him a significant figure in modern pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…